Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Care Tears
- Development stage
- Unknown
- Lead developer
- Vivimed Labs
- Administration
- Ophthalmic
01
Overview
Care Tears is a topical ophthalmic lubricant developed and manufactured by VVS Pharmaceuticals & Chemicals (a subsidiary of Vivimed Labs). It is primarily indicated for the symptomatic relief of dry eye syndrome and ocular surface irritation. The formulation typically contains carboxymethylcellulose sodium, a high-molecular-weight cellulose derivative that acts as a viscosity-enhancing agent. By mimicking the properties of natural mucins, it stabilizes the tear film, increases the residence time of moisture on the ocular surface, and provides a protective lubricating shield that reduces friction during blinking and prevents corneal desiccation.
- Brand names
- Care Tears
- Other names
- Carboxymethylcellulose sodium eye drops
Beyond the preview
Go deeper on Care Tears.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Care Tears.